Fresenius Medical Care AG

FME

DE0005785802

Healthcare Facilities & Services

Real-time Estimate Tradegate Other stock markets 09:13:38 2024-12-03 am EST			5-day change	1st Jan Change
44.33 ^EUR	+2.88%		+5.65%	+16.81%

10:21am	FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Sell rating from JP Morgan	ZD
Dec. 02	FMC stands out positively - Goldman very convinced	DP

FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Deutsche Bank gives a Neutral rating

February 21, 2024 at 06:27 am EST

Deutsche Bank's research confirms his advice and maintains his neutral opinion on the stock. The target price is unchanged and still at EUR 34.

Latest news about Fresenius Medical Care AG

FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Sell rating from JP Morgan	04:21am	ZD
FMC stands out positively - Goldman very convinced	Dec. 02	DP
Goldman puts FMC on recommendation list	Dec. 02	DP
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Goldman Sachs reiterates its Buy rating	Dec. 02	ZD
European Equities Traded in the US as American Depositary Receipts Advance Friday	Nov. 29	MT
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : UBS gives a Neutral rating	Nov. 26	ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Barclays reiterates its Neutral rating	Nov. 21	ZD
Fresenius Medical Care Receives Mechanical Circulatory Support Agreement with Premier, Inc. for the Novalung ECMO System	Nov. 19	CI
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Goldman Sachs reiterates its Buy rating	Nov. 18	ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : DZ Bank reaffirms its Neutral rating	Nov. 15	ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : UBS remains Neutral	Nov. 12	ZD
Berenberg Bank Initiates Coverage on Fresenius Medical Care With Buy Rating	Nov. 06	MT
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Deutsche Bank reiterates its Neutral rating	Nov. 06	ZD
Fresenius in high demand after figures - high since February 2022	Nov. 06	DP
Healthcare group Fresenius raises its annual targets	Nov. 06	RE
German Healthcare Group Fresenius Raises FY24 Organic Revenue Outlook	Nov. 06	MT
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Receives a Buy rating from Berenberg	Nov. 06	ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : UBS reaffirms its Neutral rating	Nov. 06	ZD
Germany's Fresenius raises 2024 forecast after Q3 beat	Nov. 06	RE
JPMorgan raises target for FMC to 37.30 euros - 'Underweight'	Nov. 06	DP
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Sell rating from JP Morgan	Nov. 05	ZD
FRESENIUS MEDICAL CARE : Some positive signs from the largest market	Nov. 05
Global markets live: Palantir soars, Boeing strike ends	Nov. 05
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Tuesday as US Heads to Polls for 2024 Presidential Elections	Nov. 05	MT
Fresenius Medical Care Q3 Earnings Rise, Revenue Decreases	Nov. 05	MT

Chart Fresenius Medical Care AG

Duration

Period

FME: Dynamic Chart

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.

Employees

113,079

Sector

Healthcare Facilities & Services

Calendar

2025-02-24 - Q4 2024 Earnings Release

More about the company